Amit T, Hochberg Z, Waters M J, Barkey R J
Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Endocrinology. 1992 Oct;131(4):1793-803. doi: 10.1210/endo.131.4.1396325.
The present study was undertaken to characterize the species specificity and diversity of lactogenic and somatogenic binding to serum among mammals and to classify GH-binding protein (GH-BP) in this group of species. Animal sera were characterized on the basis of human (h) GH and bovine (b) PRL binding levels, binding specificity toward GHs and PRLs, binding affinity constant (Ka), and the ability of a monoclonal antirabbit GH receptor antibody (MAb-7) to inhibit the binding to serum. Analyses of the results yielded a classification of the mammalian sera into five types of GH binding, which we elected to call GH-BP. The guinea pig had undetectable levels of GH-BP and was labeled type 0. Type I GH-BP was found in the mouse and the rat. hGH binding to GH-BP of type I serum was of low affinity (1.2-3.9 x 10(8) M-1) with high IC50 (approximately 100 ng/tube) and was purely somatogenic in nature. Type II GH-BP was found in the goat, sheep, and cow. Their IC50 of hGH binding was approximately 4-fold lower than that of type I GH-BP. Their binding of hGH was relatively specific and only marginally displaced by the PRLs. Type III GH-BP was found in the rabbit, horse, cat, dog, and pig. These animals' sera had high affinity binding toward hGH (4.7-9.2 x 10(9) M-1), with low IC50 (approximately 2 ng/tube) and dominant lactogenic binding. The great similarity of type III GH-BPs was further stressed by the ability of MAb-7 to inhibit [125I]hGH binding to all type III sera, but not to the other mammalian sera tested. Type IV GH-BP was found in the human and rhesus monkey sera. These were characterized by binding affinities that were intermediate between those for types II and III GH-BP and by the inability of nonprimate GHs to compete with hGH binding. To directly confirm the potent effect of the lactogenic hormones in type III GH-BP, the specific binding of bPRL to sera of type III animals was studied. [125I]bPRL-specific binding was determined under optimized assay conditions and was the highest in rabbit serum, with the following rank order being observed: rabbit >> horse = dog = pig > cat. Scatchard analysis of [125I]bPRL binding revealed linear plots with similar affinity constants (Ka) of 1.7-3.3 x 10(9) M-1.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究旨在表征哺乳动物血清中催乳素和生长激素结合的物种特异性及多样性,并对该组物种中的生长激素结合蛋白(GH-BP)进行分类。根据人(h)生长激素和牛(b)催乳素的结合水平、对生长激素和催乳素的结合特异性、结合亲和常数(Ka)以及单克隆抗兔生长激素受体抗体(MAb-7)抑制与血清结合的能力,对动物血清进行表征。对结果的分析将哺乳动物血清分为五种生长激素结合类型,我们将其命名为GH-BP。豚鼠的GH-BP水平无法检测到,被标记为0型。I型GH-BP存在于小鼠和大鼠中。hGH与I型血清的GH-BP结合亲和力低(1.2 - 3.9×10⁸ M⁻¹),IC50高(约100 ng/管),本质上纯粹是促生长的。II型GH-BP存在于山羊、绵羊和牛中。它们与hGH结合的IC50比I型GH-BP低约4倍。它们对hGH的结合相对特异,仅被催乳素轻微取代。III型GH-BP存在于兔、马、猫、狗和猪中。这些动物的血清对hGH具有高亲和力结合(4.7 - 9.2×10⁹ M⁻¹),IC50低(约2 ng/管)且主要是催乳素结合。MAb-7能够抑制[¹²⁵I]hGH与所有III型血清结合,但不能抑制其他受试哺乳动物血清结合,这进一步强调了III型GH-BP的高度相似性。IV型GH-BP存在于人和恒河猴血清中。其特征是结合亲和力介于II型和III型GH-BP之间,且非灵长类生长激素不能与hGH结合竞争。为直接证实III型GH-BP中催乳素的强效作用,研究了bPRL与III型动物血清的特异性结合。在优化的检测条件下测定[¹²⁵I]bPRL特异性结合,在兔血清中最高,观察到以下排序:兔 >> 马 = 狗 = 猪 > 猫。对[¹²⁵I]bPRL结合的Scatchard分析显示线性图,亲和力常数(Ka)相似,为1.7 - 3.3×10⁹ M⁻¹。(摘要截于400字)